CompletedNCT00725075
About this title
Adjuvant Treatment With a Glycine Uptake Inhibitor in Participants With Negative Symptoms of Schizophrenia (P05695) (MK-8435-001)
Read the official source — NCT00725075Official study titleA Multi-center, Double-blind, Flexible-dose Efficacy Trial With Org 25935 Versus Placebo as add-on Therapy in Subjects With Predominant, Persistent Negative Symptoms of Schizophrenia Treated With a Stable Dose of a Second Generation Antipsychotic (GIANT)
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaMedication studyAges 18–55
- Countries
- Sponsor
- Merck Sharp & Dohme LLC
WithdrawnNCT03997864
Official study titleAdministration of Prazosin to Prevent PTSD After Sexual Assault
This study was withdrawn before enrollment.
In AuroraPTSDMedication studyAges 18–50
- Countries
- United States
- Sponsor
- University of Colorado, Denver
CompletedNCT04844021
Official study titleA Comparative Effectiveness Trial of Strategies to Implement Firearm Safety Promotion as a Universal Suicide Prevention Strategy in Pediatric Primary Care
This study has finished and is no longer accepting participants.
Multiple locations, including AuroraSuicidalityBehavioural studyAges 18+
- Countries
- United States
- Sponsor
- Northwestern University
CompletedNCT04105868
Official study titleVisuocortical Dynamics of Affect-Biased Attention in the Development of Adolescent Depression
This study has finished and is no longer accepting participants.
In PittsburghDepressionInterventional studyAges 13–15
- Countries
- United States
- Sponsor
- University of Pittsburgh
CompletedNCT05927506
This study has finished and is no longer accepting participants.
In BaltimoreADHDObservational studyAges 12–17
- Countries
- United States
- Sponsor
- Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
CompletedNCT05476237
Official study titlePilot Implementation of Depression Screening and Treatment for Adolescents in Mozambican Primary Care
This study has finished and is no longer accepting participants.
In MaputoDepressionBehavioural studyAges 12–65
- Countries
- Mozambique
- Sponsor
- Columbia University
CompletedNCT05755165
Official study titleReducing Depression-related Stigma and Increasing Help-seeking Intentions: a Randomized Trial of Video Ads on Instagram
This study has finished and is no longer accepting participants.
In New HavenDepressionBehavioural studyAges 14–18
- Countries
- United States
- Sponsor
- Yale University
CompletedNCT06403813
Official study titleTesting the Effectiveness of a Digital Adolescent Behavioral Health Screening, Literacy, and Low-Intensity Intervention for Common Adolescent Mental Health Problems in Kenya
This study has finished and is no longer accepting participants.
In NairobiMental healthBehavioural studyAges 11–65
- Countries
- Kenya
- Sponsor
- NYU Langone Health
CompletedNCT02739932
This study has finished and is no longer accepting participants.
Multiple locations, including CalgaryDepression, Bipolarity, ...Observational studyAges 12–25
- Countries
- Canada
- Sponsor
- University of Calgary
CompletedNCT03900416
Official study titleMindfulness-based Mobile Application to Reduce Rumination in Adolescents
This study has finished and is no longer accepting participants.
In AppletonAnxiety, DepressionBehavioural studyAges 12–15
- Countries
- United States
- Sponsor
- Lawrence University
WithdrawnNCT05088915
Official study titleAdolescent BREATHE Primary Care Intervention for PTSD (PCIP) Randomized Feasibility Trial
This study was withdrawn before enrollment.
In Los AngelesPTSDBehavioural studyAges 12–22
- Countries
- United States
- Sponsor
- University of California, Los Angeles
